Items tagged with Treatment
UNITAID Tuberculosis Medicines Technology and Market Landscape (second edition) (post with simple image)
The report details current shortcomings in the tuberculosis medicines market and opportunities to improve access to lifesaving TB treatment.
Short TB regimens fall flat (post with simple image)
Two short treatment regimens for tuberculosis failed to match the standard 6 months of therapy in efficacy.
TB Alliance launches Phase 2B clinical trial of a novel TB drug regimen that could cut treatment time by half or more for a majority of TB patients (post with simple image)
NC-005 trial tests a novel regimen of bedaquiline (Sirturo), pretomanid (formerly known as PA-824), and pyrazinamide; results could pave the way for a three-month TB treatment.
Success short treatment against drug-resistant tuberculosis confirmed (post with simple image)
The result of 10 years of collaboration between the Damien Foundation Belgium and the Institute of Tropical Medicine in Antwerp (ITM) could revolutionize global tuberculosis control.
Bedaquiline as part of tailored therapy for MDR- and XDR-TB achieves impressive culture conversion rates (post with simple image)
Bedaquiline combined with other active drugs has the potential to achieve high culture conversion rates in advanced MDR- and XDR-TB cases. However, it is crucial to follow carefully all patients for severe adverse events, even after bedaquiline discontinuation.
WHO interim guidance on the use of delamanid in the treatment of MDR-TB (post with simple image)
The guidance lists five conditions that must be in place if delamanid is used to treat adults with MDR-TB.
“You see yourself vanishing and you think: I’m going to die” (post with simple image)
Andaleeb Rinquest remembers the moment she accepted, with certainty, the imminence of her own death.
Drug-resistant tuberculosis patients face dwindling treatment options (post with simple image)
Doctors believe there is greater drug resistance and complexity of TB, which disproportionally affects immigrants.
Latent TB: Shorter course of therapy effective in children (post with simple image)
In children with latent tuberculosis, 3 months of combined therapy with isoniazid and rifapentine is safe and as effective as 9 months of isoniazid alone.
Drug-resistant tuberculosis a tiny — but potent — foe in L.A. County (post with simple image)
Otsuka rejected Dr. Caitlin Reed’s attempt to obtain delamanid for her patient, Gary, who has the most drug-resistant case of TB ever identified in the United States.
Page 59 of 70 · Total posts: 0←First 58 59 60 Last→